$152.93
0.84% day before yesterday
NYSE, Sep 06, 10:10 pm CET
ISIN
US74834L1008
Symbol
DGX

Quest Diagnostics Stock price

$152.93
+6.04 4.11% 1M
+26.01 20.49% 6M
+15.05 10.92% YTD
+25.79 20.28% 1Y
-2.91 1.87% 3Y
+48.72 46.75% 5Y
+88.85 138.65% 10Y
NYSE, Closing price Fri, Sep 06 2024
-1.30 0.84%
ISIN
US74834L1008
Symbol
DGX
Sector

Key metrics

Market capitalization $17.02b
Enterprise Value $21.96b
P/E (TTM) P/E ratio 20.63
EV/FCF (TTM) EV/FCF 25.10
EV/Sales (TTM) EV/Sales 2.35
P/S ratio (TTM) P/S ratio 1.82
P/B ratio (TTM) P/B ratio 2.57
Dividend yield 1.86%
Last dividend (FY23) $2.84
Revenue growth (TTM) Revenue growth -1.50%
Revenue (TTM) Revenue $9.35b
EBIT (operating result TTM) EBIT $1.35b
Free Cash Flow (TTM) Free Cash Flow $875.00m
Cash position $271.00m
EPS (TTM) EPS $7.41
P/E forward 19.26
P/S forward 1.77
EV/Sales forward 2.28
Short interest 2.86%
Show more

Is Quest Diagnostics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Quest Diagnostics Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Quest Diagnostics forecast:

7x Buy
35%
13x Hold
65%

Analyst Opinions

20 Analysts have issued a Quest Diagnostics forecast:

Buy
35%
Hold
65%

Financial data from Quest Diagnostics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
9,346 9,346
1% 1%
100%
- Direct Costs 6,373 6,373
0% 0%
68%
2,973 2,973
5% 5%
32%
- Selling and Administrative Expenses 1,166 1,166
9% 9%
12%
- Research and Development Expense - -
-
-
1,807 1,807
1% 1%
19%
- Depreciation and Amortization 453 453
2% 2%
5%
EBIT (Operating Income) EBIT 1,354 1,354
3% 3%
14%
Net Profit 836 836
6% 6%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Quest Diagnostics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quest Diagnostics Stock News

Neutral
PRNewsWire
10 days ago
SECAUCUS, N.J. , Aug. 28, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York City on Frid...
Neutral
PRNewsWire
12 days ago
SECAUCUS, N.J. and TORONTO , Aug. 26, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the completion of its acquisition of LifeLabs from OMERS.
Neutral
PRNewsWire
17 days ago
Transaction to broaden access to innovative, quality diagnostic information services powering affordable care in Ohio SECAUCUS, N.J., and CLEVELAND , Aug. 21, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, and University Hospitals, one of the nation's leading nonprofit health systems and academic medical centers, today announced a defi...
More Quest Diagnostics News

Company Profile

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Head office United States
CEO James Davis
Employees 48,000
Founded 1967
Website www.questdiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today